ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $24,000 | +4.3% | 16,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $23,000 | -37.8% | 16,000 | -23.8% | 0.01% | -28.6% |
| Q3 2016 | $37,000 | +32.1% | 21,000 | +31.2% | 0.01% | +16.7% |
| Q2 2016 | $28,000 | -12.5% | 16,000 | 0.0% | 0.01% | -14.3% |
| Q1 2016 | $32,000 | -3.0% | 16,000 | -5.9% | 0.01% | 0.0% |
| Q4 2015 | $33,000 | 0.0% | 17,000 | -1.2% | 0.01% | -12.5% |
| Q3 2015 | $33,000 | -62.5% | 17,200 | -9.0% | 0.01% | -63.6% |
| Q2 2015 | $88,000 | +528.6% | 18,900 | +361.0% | 0.02% | – |
| Q4 2014 | $14,000 | 0.0% | 4,100 | -72.7% | 0.00% | -100.0% |
| Q1 2014 | $14,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |